Synthesis of deoxygenated α(1 → 5)-linked arabinofuranose disaccharides as substrates and inhibitors of arabinosyltransferases of Mycobacterium tuberculosis

被引:16
作者
Pathak, Ashish K. [1 ]
Pathak, Vibha [1 ]
Suling, William J. [1 ]
Riordan, James R. [1 ]
Gurcha, Sudagar S. [2 ]
Besra, Gurdyal S. [2 ]
Reynolds, Robert C. [1 ]
机构
[1] So Res Inst, Drug Discovery Div, Birmingham, AL 35255 USA
[2] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England
基金
英国医学研究理事会;
关键词
Arabinosyltransferases; Mycobacterium tuberculosis; Deoxyarabinofuranose; 2-Fluoroarabinofuranose; Disaccharides; Inhibitors; DRUG-RESISTANT TUBERCULOSIS; HIV-INFECTED PATIENTS; STEREOSELECTIVE-SYNTHESIS; MULTIDRUG-RESISTANT; TRANSFERASE-ACTIVITY; DERIVATIVES; ANALOGS; GLYCOSYLATION; BIOSYNTHESIS; EPIDEMIOLOGY;
D O I
10.1016/j.bmc.2008.11.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Arabinosyltransferases (AraTs) play a critical role in mycobacterial cell wall biosynthesis and are potential drug targets for the treatment of tuberculosis, especially multi-drug resistant forms of M. tuberculosis (MTB). Herein, we report the synthesis and acceptor/inhibitory activity of Araf alpha(1 -> 5) Araf disaccharides possessing deoxygenation at the reducing sugar of the disaccharide. Deoxygenation at either the C-2 or C-3 position of Araf was achieved via a free radical procedure using xanthate derivatives of the hydroxyl group. The alpha(1 -> 5)-linked disaccharides were produced by coupling n-octyl alpha-Araf 2-/3-deoxy, 2-fluoro glycosyl acceptors with an Araf thioglycosyl donor. The target disaccharides were tested in a cell free mycobacterial AraTs assay as well as an in vitro assay against MTB H37Ra and M. avium complex strains. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:872 / 881
页数:10
相关论文
共 50 条
[41]   Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis [J].
Lu, Guo-Liang ;
Tong, Amy S. T. ;
Conole, Daniel ;
Sutherland, Hamish S. ;
Choi, Peter J. ;
Franzblau, Scott G. ;
Upton, Anna M. ;
Lotlikar, Manisha U. ;
Cooper, Christopher B. ;
Denny, William A. ;
Palmer, Brian D. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (22)
[42]   Synthesis and in vitro antitubercular activity of 4-aryl/alkylsulfonylmethylcoumarins as inhibitors of Mycobacterium tuberculosis [J].
Jeyachandran, Malaichamy ;
Ramesh, Penugonda ;
Sriram, Dharmarajan ;
Senthilkumar, Palaniappan ;
Yogeeswari, Perumal .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) :4807-4809
[43]   The role of triacylglycerols and repurposing DGAT1 inhibitors for the treatment of Mycobacterium tuberculosis [J].
Moorey, Alice R. ;
Besra, Gurdyal S. .
CELL SURFACE, 2022, 8
[44]   Nanomolar inhibitors of Mycobacterium tuberculosis glutamine synthetase 1: Synthesis, biological evaluation and X-ray crystallographic studies [J].
Couturier, Cedric ;
Silve, Sandra ;
Morales, Renaud ;
Pessegue, Bernard ;
Llopart, Sylvie ;
Nair, Anil ;
Bauer, Armin ;
Scheiper, Bodo ;
Poeverlein, Christoph ;
Ganzhorn, Axel ;
Lagrange, Sophie ;
Bacque, Eric .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (07) :1455-1459
[45]   Synthesis and biological evaluation of isatin oxime ether-tethered aryl 1H-1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis [J].
Kancharla, Sampath Kumar ;
Birudaraju, Saritha ;
Pal, Arani ;
Reddy, L. Krishnakanth ;
Reddy, Eda Rami ;
Vagolu, Siva Krishna ;
Sriram, Dharmarajan ;
Bonige, Kishore Babu ;
Korupolu, Raghu Babu .
NEW JOURNAL OF CHEMISTRY, 2022, 46 (06) :2863-2874
[46]   Optimization and Evaluation of 5-Styryl-Oxathiazol-2-one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents [J].
Russo, Francesco ;
Gising, Johan ;
Akerbladh, Linda ;
Roos, Annette K. ;
Naworyta, Agata ;
Mowbray, Sherry L. ;
Sokolowski, Anders ;
Henderson, Ian ;
Alling, Torey ;
Bailey, Mai A. ;
Files, Megan ;
Parish, Tanya ;
Karlen, Anders ;
Larhed, Mats .
CHEMISTRYOPEN, 2015, 4 (03) :342-362
[47]   1,5-Disubstituted 1,2,3-triazole linked disaccharides: Metal-free syntheses and screening of a new class of ribonuclease A inhibitors [J].
Kayet, Anirban ;
Datta, Dhrubajyoti ;
Das, Ashrukana ;
Dasgupta, Swagata ;
Pathak, Tanmaya .
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (02) :455-462
[48]   Design of Selective Substrates and Activity-Based Probes for Hydrolase Important for Pathogenesis 1 (HIP1) from Mycobacterium tuberculosis [J].
Lentz, Christian S. ;
Ordonez, Alvaro A. ;
Kasperkiewicz, Paulina ;
La Greca, Florencia ;
O'Donoghue, Anthony J. ;
Schulze, Christopher J. ;
Powers, James C. ;
Craik, Charles S. ;
Drag, Marcin ;
Jain, Sanjay K. ;
Bogyo, Matthew .
ACS INFECTIOUS DISEASES, 2016, 2 (11) :807-815
[49]   Studies Toward the Synthesis of Inhibitors of Mycobacterium tuberculosis Cell-Wall Biosynthesis: The Assembly of Triazole-Linked 1,6-α-D-Oligomannosides via Click CuAAC [J].
Lo Conte, Mauro ;
Chambery, Angela ;
Marra, Alberto ;
Dondoni, Alessandro .
SYNLETT, 2009, (16) :2679-2681
[50]   Synthesis and interaction of terminal unsaturated chemical probes with Mycobacterium tuberculosis CYP124A1 [J].
Diaz-Storani, Luz ;
Clary, Anaelle A. ;
Moreno, Diego M. ;
Ballari, Maria Sol ;
Porta, Exequiel O. J. ;
Bracca, Andrea B. J. ;
Johnston, Jonathan B. ;
Labadie, Guillermo R. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 44